| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |